Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>COFOE MEDICAL (01187.HK) Net Proceeds for H-shr Listing Estimated to Be $1B+ w/ Entry Fee $3,972.67; Cornerstone Investors Include LENS
Recommend 22 Positive 23 Negative 15 |
||||
|
||||
|
COFOE MEDICAL (01187.HK), a leading Chinese provider of home care medical devices that is already listed on the A-share market, kicked off its IPO from today (27th) until Thursday (30th), offering 27 million H-shares globally, with 10% allocated to the Hong Kong public offering and 90% to the international placement. The maximum offer price is $39.33 per share, while the entry fee for a board lot of 100 shares is $3,972.67. The shares are expected to be listed on 6 May. Huatai International and BNP Paribas are its joint sponsors. The Company introduced 12 cornerstone investors, including LENS (06613.HK) and SINOHEALTH TECH (02361.HK), etc.. The cornerstone investors have subscribed for a total of approx. US$48.49 million and will subscribe for 9.6543 million offer shares at the maximum offer price, representing approx. 35.76% of its share offering. Based on the maximum offer price of $39.33, the net proceeds from the listing are estimated to be approx. $1.007 billion. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
